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The Fen1 extrahelical 3'-flap pocket is conserved from archaea to
human and regulates DNA substrate specificity
Abstract
Fen1 is a key enzyme for the maintenance of genetic stability in archaea and eukaryotes and is classified
as a tumor suppressor. Very recent structural data obtained from Archaeoglobus fulgidus Fen1 suggest
that an extrahelical 3'-flap pocket is responsible for substrate specificity, by binding to the unpaired
3'-flap and by opening and kinking the DNA. Since the extrahelical 3'-flap pocket in archaeal Fen1
contains seven amino acids that are conserved to a great extent in human Fen1, we have mutated the
four conserved or all seven amino acids in the human Fen1 extrahelical 3'-flap pocket to alanine. Our
data suggest that the human extrahelical 3'-flap pocket mutants have lost substrate specificity to the
double-flap DNA. Moreover, loss of high affinity for the unpaired 3'-flap suggests that the extrahelical
3'-flap pocket is essential for recognition and processing of the 'physiological' template. Human PCNA
could stimulate the human Fen1 extrahelical 3'-flap pocket mutants but not restore their specificity. Thus
the substrate specificity of Fen1 has been functionally conserved over a billion years from archaea to
human.
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ABSTRACT
Fen1 is a key enzyme for the maintenance of genetic
stability in archaea and eukaryotes and is classi®ed
as a tumor suppressor. Very recent structural
data obtained from Archaeoglobus fulgidus Fen1
suggest that an extrahelical 3¢-¯ap pocket is respon-
sible for substrate speci®city, by binding to the
unpaired 3¢-¯ap and by opening and kinking the
DNA. Since the extrahelical 3¢-¯ap pocket in
archaeal Fen1 contains seven amino acids that are
conserved to a great extent in human Fen1, we have
mutated the four conserved or all seven amino
acids in the human Fen1 extrahelical 3¢-¯ap pocket
to alanine. Our data suggest that the human extra-
helical 3¢-¯ap pocket mutants have lost substrate
speci®city to the double-¯ap DNA. Moreover, loss of
high af®nity for the unpaired 3¢-¯ap suggests
that the extrahelical 3¢-¯ap pocket is essential for
recognition and processing of the `physiological'
template. Human PCNA could stimulate the human
Fen1 extrahelical 3¢-¯ap pocket mutants but not
restore their speci®city. Thus the substrate speci®-
city of Fen1 has been functionally conserved over a
billion years from archaea to human.
INTRODUCTION
Flap endonuclease 1 (Fen1) belongs to a family of structure-
speci®c nucleases that are evolutionarily conserved between
Archaea and Eukarya (reviewed in 1±4). Its ¯ap endonuclease
activity as well as its 5¢®3¢ exonuclease activity allows Fen1
to remove the RNA primers during lagging strand synthesis
and damaged DNA fragments in various DNA repair pathways
(reviewed in 4). Based on protein sequence comparison and
biochemical assays, two major conserved motifs, the N
(N-terminal) and I (intermediate) motifs, were found to be
essential for the nuclease activities of Fen1 (3,5). A third motif
at the C-terminal end is involved in the interaction with
proliferating cell nuclear antigen (PCNA) (3,6,7). All crystal
structures of Fen1 homologs solved to date (8±11) showed a
conserved helical arch located above the globular domain that
contains the active site. This ¯exible loop, in addition to the
catalytic site, was shown to be essential for ¯ap cleavage (12)
and it has been proposed that the 5¢-end of the DNA ¯ap could
thread through the hole of the loop tracking the length of the
5¢-tail (13).
The cleavage rate on a single-5¢-¯ap substrate, which is
usually used to measure Fen1 endonuclease activity, is
signi®cantly increased by the presence of a 1 bp overlap
between the upstream and downstream duplex regions. This
stimulatory effect has been reported previously for Fen1
homologs from Archaea to Eukarya (13±19). When the
cleavage speci®city of Fen1 nucleases was analyzed on a
single-5¢-¯ap substrate, the heterogeneity in cleavage position
encountered (either at the junction or 1 nt into the annealed
region) seemed to be inconsistent with the proposed roles of
Fen1 in DNA replication and repair. In the case of the
substrate with an overlap between the upstream and down-
stream duplexes (also called the double-¯ap substrate), the site
of cleavage was found to be exclusively 1 nt into the annealed
region (16,18,19), allowing DNA ligase I to seal the resulting
nicks (16,18). In contrast, a portion of the products from the
`traditional' single-5¢-¯ap substrate was not ligated. This led
to the proposition that there is a region or pocket in the enzyme
that speci®cally recognizes that 3¢-¯ap nucleotide (16). A
study of the T5 5¢-nuclease also suggested that there could be
room for an additional base at the primer terminus (10), and
analysis of the interaction between the 5¢-nuclease domain of
bacterial DNA polymerase I and different 3¢-tailed substrates
also supported the binding of 1±2 nt at the 3¢-terminus into an
enzyme binding pocket (20).
Two additional ®ndings suggest that a double-¯ap is formed
and cleaved during eukaryotic DNA replication in vivo.
Firstly, a rad27p G240D mutant (rad27p is the Saccharomyves
cerevisiae homolog of Fen1) exhibited very low endo- and
exonuclease activities on a conventional single-¯ap substrate,
however, it ef®ciently cleaved a double-¯ap substrate (18).
The mutant showed a mutator phenotype but it could grow
with almost equal ef®ciency as the wild-type. Secondly, a dual
mode of binding was shown for human Fen1 to a double-¯ap
substrate at a 1:1 molar ratio (19), whereas a 100-fold excess
of Fen1 to a single-¯ap substrate was required to obtain
complex formation.
Very recently, the structure of the archaeon Archaeoglobus
fulgidus Fen1 bound to a duplex DNA was solved, and FRET
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experiments and modeling suggest that A.fulgidus Fen1 binds
to the unpaired DNA 3¢-end (3¢-¯ap), opens and kinks the
DNA and promotes conformational closing of the ¯exible
helical clamp to facilitate 5¢ cleavage speci®city (11). This led
us to analyze whether the extrahelical 3¢-¯ap pocket is also
conserved in human Fen1 and to study the effect of replacing
the seven amino acids, which comprise this extrahelical 3¢-¯ap
pocket, by alanine.
MATERIALS AND METHODS
Nucleic acid substrates
Oligonucleotides used to prepare the substrates for Fen1
nuclease assays were purchased from Microsynth GmbH
(Balgach, Switzerland) and their sequences are listed in
Table 1. They were labeled at the 5¢-end in a buffer containing
70 mM Tris±HCl (pH 7.6), 10 mM MgCl2, 5 mM DTT, an
equimolar amount of [g-32P]ATP to the 5¢-end to be labeled
and T4 polynucleotide kinase (New England Biolabs) for 45
min at 37°C. T4 polynucleotide kinase was heat-inactivated at
80°C for 15 min and free ATP was removed on MicrospinÔ
G-25 columns. To generate the substrates for the nuclease
assays, the appropriate oligonucleotides were mixed in a 1:1
molar ratio in a buffer containing 50 mM Tris±HCl (pH 7.4),
150 mM NaCl, heated to 75°C and slowly cooled to room
temperature. The substrates for the electromobility shift assays
were prepared according to the same protocol.
Enzymes and proteins
Human Fen1 cDNA was cloned into the pET 23d vector
(Novagen) (6). The DP mutant was puri®ed as described
previously (6). Wild-type and mutant proteins were over-
expressed in Escherichia coli strain BL21(DE3)pLysS as
histidine-tagged proteins and puri®ed to near homogeneity
using nickel charged metal chelating resin (HiTrap;
Amersham Pharmacia Biotech) and SP Sepharose using fast
protein liquid chromatography. Human PCNA was produced
in E.coli using the plasmid pT7/hPCNA and puri®ed to
homogeneity as described (21).
Generation of two extrahelical 3¢-¯ap pocket mutant
Fen1 enzymes
Mutagenic PCR was performed using DyNAzymeÔ
(Finnzymes) and the primers listed in Table 2. Following
digestion of the parental, non-mutated pET23d vector tem-
plate with DpnI (New England Biolabs), mutated plasmids
were transformed into E.coli and plasmid DNA was isolated.
To introduce all the desired mutations, this protocol was
repeated several times. Finally, DNA sequencing reactions
were performed to verify introduction of the desired mutations
and absence of additional mutations.
Fen1 nuclease assay
Assay conditions were identical to those described previously
(19). The enzyme titration assays were performed in a ®nal
volume of 12.5 ml containing the following ingredients: 40 mM
Tris±HCl (pH 7.5), 10 mM MgCl2, 1 mM dithiothreitol,
200 mg/ml bovine serum albumin and 50 fmol DNA substrate.
After addition of wild-type (wt) and mutant Fen1, reactions
were incubated for 15 min at 30°C and stopped with 2.53 stop
buffer (95% formamide, 20 mM EDTA, 0.05% each
bromophenol blue and xylene cyanol). Products were separ-
ated on 19% denaturing polyacrylamide gels and visualized by
autoradiography. For all experiments, the product size was
determined by using appropriate radioactively labeled oligo-
nucleotides (nt) of identical sequence to the template. For
PCNA stimulation of Fen1, reactions were performed as
Table 1. Oligonucleotides used to create the Fen1 substrates used in this study
Oligonucleotide Size Sequence (5¢®3¢)
Upstream primers
Up1 30mer TCGAGGTCGACGGTATCGATAAGCTTGATA
Up2 31mer TCGAGGTCGACGGTATCGATAAGCTTGATAC
Up3 31mer TCGAGGTCGACGGTATCGATAAGCTTGATAT
Up4 32mer TCGAGGTCGACGGTATCGATAAGCTTGATACG
Downstream primers
Dn1 19mer TCGAATTCCTGCAGCCCGG
Dn2 39mer GTCATGATAGATCTGATCGCTCGAATTCCTGCAGCCCGG
Template
T 49mer CCGGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGA
Unannealed nucleotides are in bold.
Table 2. Primers used to create the Fen1 mutants used in this study
Mutant Amino acid Sequence (5¢®3¢)
LTFR L53 GGGTGGGGATGTGGCGCAGAATGAGGAGGG
T61 GGAGGGTGAGACCGCTAGCCACCTGATGGG
F316 R320 GTGTGGTGAAAAGCAGGCCTCTGAGGAGGCAATCCGCAGTGGG
LQTKFSR L53 Q54 CGCCAGGGTGGGGATGTGGCCGCGAATGAGGAGGGTGAGACC
T61 GGAGGGTGAGACCGCTAGCCACCTGATGGG
K314 F316 S317 R320 GTTCATGTGTGGTGAAGCGCAGGCCGCGGAGGAGGCAATCCGCAGTGGGG
Mutated nucleotides are in bold.
Nucleic Acids Research, 2004, Vol. 32, No. 8 2521
described above except that the buffer was replaced by 50 mM
Bis±Tris (pH 6.5) and 100 mM NaCl was added (22). For
calculation of PCNA stimulation, the gels were quanti®ed on a
PhosphorImager using the ImageQuant software (Molecular
Dynamics). The SEM was calculated from the results of three
independent experiments.
Electrophoresis mobility shift assay (EMSA) for Fen1
Assay conditions were the same as described previously (19).
The binding reactions were carried out in a ®nal volume of 20
ml containing 50 mM Tris±HCl (pH 8.0), 10 mM NaCl, 5 mM
EDTA, 100 mg bovine serum albumin, 4% Ficoll, 50 fmol
labeled substrate and the indicated amounts of wt or mutant
Fen1. After incubation for 10 min at room temperature,
reactions were loaded on 6% polyacrylamide gels containing
0.53 TBE and run ®rst at 50 V for 45 min and then at 100 V
for 90 min. Finally, the bands were visualized by autoradio-
graphy.
Pull down assay with His6±Fen1
Aliquots of 8 mg Fen1 wt or mutant proteins were bound on
Ni2+ beads. To prevent non-speci®c binding, the beads were
pretreated with 10 mg Sf9 cell extract prior to the addition of
460 ng PCNA in 50 mM Tris±HCl (pH 8.0), 150 mM NaCl,
0.025% NP-40 and incubated for 2 h at 4°C. The beads were
then washed ®ve times with the same buffer, but in addition 60
mM imidazole was included. Bound proteins were eluted by
boiling in SDS±PAGE loading buffer and resolved on a 12%
SDS±PAGE gel. PCNA was detected by western blot analysis
using the PC10 antibody (Santa Cruz Biotechnology).
RESULTS
The amino acids in the extrahelical 3¢-¯ap pocket of
human Fen1 are conserved from archaea to human
Modeling of the extrahelical 3¢-¯ap pocket from the structure
of the archaeon A.fulgidus Fen1 (11) suggests that this region
might be very similar in human Fen1, since seven amino acids
within this extrahelical 3¢-¯ap pocket are conserved in Fen1
from Archaea (Methanococcus janaschii, Pyrococcus abyssi
and A.fulgidus), to two yeasts (Saccharomyces cerevisiae and
Schizosaccaromyces pombe), to a ¯y (Drosophila melanoga-
ster), to a frog (Xenopus laevis) and to human (Homo sapiens)
(Fig. 1A and B). The human amino acids L53, Q54, T61,
K314, F316, S317 and R320 are all in the extrahelical 3¢-¯ap
Figure 1. The amino acids in the extrahelical 3¢-¯ap pocket of human Fen1.
(A) Amino acid alignments of different Fen1 proteins. HSA, Homo sapiens;
DME, Drosophila melanogaster; XLA, Xenopus laevis; SCE,
Saccharomyces cerevisiae; SPO, Schizosaccharomyces pombe; AFU,
Archaeoglobus fulgidus; PAB, Pyrococcus abyssi; MJA, Methanococcus
janaschii. Identical amino acids are shaded black, similar amino acids grey.
The asterisks indicate the seven amino acids in the extrahelical 3¢-¯ap
pocket of human Fen1: L53, Q54, T61, K314, F316, S317 and R320.
(B) The 3-dimensional structure of human Fen1 was modeled with the
Swiss-Pdb viewer according to the structure of M.janaschii Fen1 (9).
(C) Two mutant human Fen1 proteins were designed: Fen1 (LTFR), where
the four conserved amino acids (L53, T61, F316 and R320) were mutated to
alanine; Fen1 (LQTKFSR) where the seven amino acids L53, Q54, T61,
K314, F316, S317 and R320 were mutated to alanine. Mutagenesis,
recombinant production and puri®cation were carried out as described in
Materials and Methods. (Left) Fen1 (LTFR) and Fen1 wt, 5 and 10 mg each;
(right) Fen1 (LQTKFSR) and Fen1 wt, 5 and 10 mg each were analyzed by
10% SDS±PAGE.
2522 Nucleic Acids Research, 2004, Vol. 32, No. 8
pocket (Fig. 1B) and correspond to the amino acids L47, K48,
T55, H308, F310, S311 and R314 of A.fulgidus (see ®g. 1C in
11). We have constructed two mutants of human Fen1. First,
the four conserved amino acids L53, T61, F316 and R320 and,
second, the seven amino acids L53, Q54, T61, K314, F316,
S317 and R320 (Fig. 1A) were mutated to alanine, since these
amino acids are important for A.fulgidus Fen1 binding to the
unpaired DNA 3¢-end. The two mutants carrying a His tag,
called Fen1 (LTFR) and Fen1 (LQTKFSR), respectively, were
produced in bacteria and puri®ed to apparent homogeneity
(Fig. 1C). The preparations were free of contaminating
nucleases, as tested on linear and supercoiled plasmid DNA
(data not shown).
Human Fen1 extrahelical 3¢-¯ap pocket mutants have
reduced exonuclease activities and a less stringent
cleavage pattern
First we tested exonuclease activities on a nicked DNA
substrate and on a nicked substrate containing an unpaired 3¢-
end. From Figure 2 it is evident that both mutants had a greatly
reduced activity compared to Fen1 wt (compare lanes 4±6 to
7±9 and 10±12, respectively). In addition, both mutants
synthesized a two base product compared to the one base
product of Fen1 wt. Furthermore, the activity of Fen1
(LQTKFSR) is considerably lower than the four amino acid
mutant Fen1 (LTFR). This result is surprising since we would
expect no effect on a substrate lacking a 3¢-¯ap when the 3¢-
¯ap pocket is mutated. This might be explained by a tendency
of Fen1 wt to bind to the 3¢-end of the nick and to induce a 3¢-
¯ap. A similar activity pro®le was found with the unpaired
DNA 3¢-end substrate (Fig. 2, lanes 13±22) and the previously
observed stimulation of Fen1 wt by the unpaired 3¢-¯ap (19) is
lost in both mutants. In summary, the two extrahelical 3¢-¯ap
pocket mutants have reduced exonuclease activities, which are
coupled with a loss of product speci®city. The effect was more
pronounced with Fen1 (LQTKFSR), suggesting that the
extrahelical 3¢-¯ap pocket is important for the exonuclease
activity of human Fen1.
Human Fen1 extrahelical 3¢-¯ap pocket mutants have
reduced endonuclease activities and a less stringent
cleavage pattern
It has been found that Fen1 has high cleavage speci®city for
double-¯ap DNA substrates and this speci®city suggests that
Fen1 contains a region or pocket that can speci®cally bind to
the 3¢-¯ap (16). This has been con®rmed at the structural level
for archaeal Fen1, where this binding induces a kinking of the
DNA substrate (11). We therefore next tested different ¯ap
DNA substrates and compared the two extrahelical 3¢-¯ap
Fen1 mutants with their wild-type counterpart. Figure 3A
shows that Fen1 wt has a clear preference for double-¯ap
substrates (compare lanes 4±6 with lanes 8±10 and 12±14 in
Fig. 3A). A 2 nt non-complementary ¯ap mainly resulted in a
1 nt longer product (22 nt), likely due to the transition to the
optimal one nt 3¢-¯ap (lanes 16±18). When the four amino acid
extrahelical 3¢-¯ap pocket mutant Fen1 (LTFR) was tested
with four DNA substrates we found that, ®rst, >100 times
more molecules of Fen1 were required for cutting, second, two
bands appeared with all four substrates tested and, third, the
previously observed stimulation by the unpaired 3¢-¯ap (19) is
lost (compare lanes 4 and 8 in Fig. 3B with lanes 4 and 8 in
Fig. 3A). With the `physiological' complementary 3¢-¯ap
substrate the product was mainly 1 nt longer (22 nt) than with
Fen1 wt and only a small proportion of the correct 21 nt
product was made (compare lanes 12±14 of Fig. 3A and B).
For the single-¯ap and non-complementary 3¢-¯ap substrates
two products appeared (21 and 22 nt), whereas the wild-type
showed a clear preference for the 21 nt product (compare lanes
4±6 and 8±10 of Fig. 3B with lanes 4±6 and 8±10 of Fig. 3A).
This suggests that substrate speci®city was severely hampered
in this mutant. Finally, the seven amino acid extrahelical 3¢-
¯ap pocket mutant Fen1 (LQTKFSR) showed a similar altered
cleavage pattern to the Fen1 (LTFR) mutant and with the
`physiological' complementary 3¢-¯ap substrate the product
was exclusively 1 nt longer (22 nt) than with Fen1 wt (lanes
12±14 of Fig. 3C). Only the 2 nt non-complementary 3¢-¯ap
substrate showed the expected product of 22 nt (lanes 16±18 in
Fig. 3C). These data suggest that replacement of only the four
conserved amino acids L53, T61, F316 and R320 resulted in a
severe loss of substrate speci®city, while replacement of all
seven conserved amino acids L53, Q54, T61, K314, F316,
S317 and R320 resulted in complete loss of the 3¢-¯ap
speci®city.
Human Fen1 extrahelical 3¢-¯ap pocket mutants have
lost the speci®c binding to double-¯ap DNA
EMSA recently showed two binding modes of human Fen1,
but only with the double-¯ap DNA structure containing a 3¢-
¯ap (19). Using gel ®ltration experiments we could show that
the faster migrating complex had a molecular weight which
corresponded to a 1:1 complex between Fen1 and the double-
¯ap DNA (data not shown). Again as expected, Fen1 wt
Figure 2. Both human Fen1 extrahelical 3¢-¯ap pocket mutants have
reduced exonuclease activities and a less stringent cleavage pattern. Fen1
exonuclease activities were determined as described in Materials and
Methods on a nicked (lanes 3±12) and on a 3¢-overhang nicked (lanes
13±22) DNA substrate. Lanes 1 and 2, oligonucleotide (nt) markers of 1, 2
and 3 nt; lanes 3 and 13, no enzyme control; lanes 4±6 and 14±16, 5, 50
and 500 ng Fen1 wt; lanes 7±9 and 17±19, 5, 50 and 500 ng Fen1 (LTFR);
lanes 10±12 and 20±22, 5, 50 and 500 ng Fen1 (LQTKFSR). DNA substrate
and product size (in nt) are indicated on the left of the ®gure.
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revealed two binding modes on both double-¯ap substrates
(Fig. 4A, lanes 7±10 and 12±15). This dual binding mode was
lost with both extrahelical 3¢-¯ap pocket mutants (Fig. 4B and
C). In contrast to a Fen1 mutant lacking the C-terminal 20
amino acids, which is completely unable to bind DNA (6),
these two mutants have not lost the property of general DNA
binding, but rather DNA-speci®c binding. Although the
slightly weaker binding of the Fen1 (LTQKFSR) mutant to
Figure 3. Both human Fen1 extrahelical 3¢-¯ap pocket mutants have reduced endonuclease activities and a less stringent cleavage pattern. (A) The amounts
of Fen1 wt indicated at the top of the autoradiogram were tested on a ¯ap (SF) (lanes 3±6), on a non-complementary double-¯ap (DFnc) (lanes 7±10), on a
complementary double-¯ap (DFc) (lanes 11±14) and on a two 3¢-nucleotide overhang (DF2nc) (lanes 15±18) DNA substrate as outlined in Materials and
Methods. Lanes 1 and 2 contain oligonucleotide (nt) markers of 20 and 22 nt and 21 and 23 nt, respectively. (B) The amounts of Fen1 (LTFR) indicated at
the top of the autoradiogram were tested on a ¯ap (SF) (lanes 3±6), on a non-complementary double-¯ap (DFnc) (lanes 7±10), on a complementary double-¯ap
(DFc) (lanes 11±14) and on a two 3¢-nucleotide overhang (DF2nc) (lanes 15±18) DNA substrate as outlined in Materials and Methods. Lanes 1 and 2 contain
oligonucleotide (nt) markers of 20 and 22 nt and 21 and 23 nt, respectively. (C) Shown on the top of the autoradiogram, the indicated amounts of Fen1
(LQTKFSR) were tested on a ¯ap (SF) (lanes 3±6), on a non-complementary double-¯ap (DFnc) (lanes 7±10), on a complementary double-¯ap (DFc) (lanes
11±14) and on a two 3¢-nucleotide overhang (DF2nc) (lanes 15±18) DNA substrate as outlined in Materials and Methods. Lanes 1 and 2 contain
oligonucleotide (nt) markers of 20 nt and 22 nt, or 21 nt and 23 nt, respectively. Product size (in nt) is indicated on the left of the ®gure.
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the different DNA ¯ap substrates may indicate a perturbation
of its structure by the seven amino acid replacements, our data
in Figures 2 and 3 show that this mutant is still enzymatically
active. Therefore, we conclude that the Fen1 (LQTKFSR)
mutant has not lost its general DNA binding ability. These
data suggest that the mutant Fen1 proteins could still bind to
DNA but were no longer able to properly accommodate the
3¢-¯ap and kink the DNA substrate. Fluorescent resonance
energy transfer (FRET) experiments with A.fulgidus Fen1 are
in agreement with these observations (11). In conclusion, the
extrahelical 3¢-¯ap pocket mutant Fen1 enzymes were no
longer able to distinguish the `physiological' substrate from
other ones.
Human Fen1 extrahelical 3¢-¯ap pocket mutants can
interact and are stimulated by PCNA, but the normal
cleavage pattern cannot be restored by PCNA
PCNA has been shown to bind to Fen1 and to stimulate its
activity by >50 times under physiological salt conditions (22±
25). We therefore tested the two extrahelical 3¢-¯ap pocket
mutants for their capacity to bind PCNA. Both mutants bound
PCNA, the four amino acid mutant Fen1 (LTFR) as strongly as
Fen1 wt, while the binding of the seven amino acid mutant
Fen1 (LQTKFSR) to PCNA was reduced by 50% (Fig. 5A).
These binding experiments were nicely con®rmed in a PCNA
stimulation assay (Fig. 5B±D). On a single-¯ap DNA
substrate, Fen1 wt was stimulated by PCNA in a dose-
dependent manner and this stimulation was speci®c, since
BSA showed no stimulatory effect (Fig. 5B, compare lanes
5±9 with lanes 10±14). Both extrahelical 3¢-¯ap pocket
mutants were stimulated by PCNA (Fig. 5C), although 100
times more Fen1 (LTFR) or 250 times more Fen1 (LQTKFSR)
had to be included to see a similar effect (compare Fig. 5C
with B). Quanti®cation of the stimulation showed that the four
amino acid mutant Fen1 (LTFR) was stimulated by PCNA to
the same extent as Fen1 wt, whereas the seven amino acid
mutant Fen1 (LQTKFSR) was stimulated to a lesser extent
(Fig. 5D), probably due to its reduced interaction with PCNA
(Fig. 5A). Finally, we analyzed whether PCNA could restore
the substrate speci®city of the mutant Fen1 enzymes. As seen
from Figure 5B, Fen1 wt mainly synthesized a product of 21 nt,
while the two mutants produced about equal amounts of the 21
and 22 nt cleavage products (Fig. 5C). These data are in
agreement with those seen in Figure 3. In summary, the
extrahelical 3¢-¯ap pocket mutant Fen1 enzymes could be
stimulated by PCNA but the substrate speci®city could not be
restored.
DISCUSSION
The substrate speci®city of Fen1 is evolutionarily
conserved
The data presented in this work clearly indicate that the
substrate speci®city of Fen1 is conserved through evolution in
an extraordinary way and that this conservation is seen in the
structural similarity of the hydrophobic wedge in general and
the extrahelical 3¢-¯ap pocket in particular. The biochemical
and functional data presented in this paper suggest that the
extrahelical 3¢-¯ap pocket, as structurally identi®ed in the
archaeon A.fulgidus Fen1 (11), appears to be almost identical
to human Fen1. The observation that a 1 nt double-¯ap
structure is the optimal substrate for human Fen1 and that with
this substrate a DNA±protein complex could be observed at a
1:1 molar ratio (19 and data not shown) suggested that a
double-¯ap substrate containing a 1 nt 3¢-tail is the in vivo
Figure 4. Both human Fen1 extrahelical 3¢-¯ap pocket mutants have lost
speci®c binding to double-¯ap DNA. The EMSA assays were carried out as
outlined in Materials and Methods. (A) Aliquots of 0, 5, 50, 200 and 400 ng
Fen1 wt were tested on a ¯ap (SF) (lanes 1±5), on a non-complementary
double-¯ap (DFnc) (lanes 6±10), on a complementary double-¯ap (DFc)
(lanes 11±15) and on a two 3¢-nucleotide overhang (DF2nc) (lanes 16±20)
DNA substrate. (B) Aliquots of 0, 5, 50, 200 and 400 ng Fen1 (LTFR) were
tested on a ¯ap (SF) (lanes 1±5), on a non-complementary double-¯ap
(DFnc) (lanes 6±10), on a complementary double-¯ap (DFc) (lanes 11±15)
and on a two 3¢-nucleotide overhang (DF2nc) (lanes 16±20) DNA substrate.
(C) Aliquots of 0, 5, 50, 200 and 400 ng Fen1 (LQTKFSR) were tested on
a ¯ap (SF) (lanes 1±5), on a non-complementary double-¯ap (DFnc) (lanes
6±10), on a complementary double-¯ap (DFc) (lanes 11±15) and on a two
3¢-nucleotide overhang (DF2nc) (lanes 16±20) DNA substrate.
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substrate for human Fen1. This has been described previously
for the Fen1 homolog in yeast, rad27p (18). This double-¯ap
substrate could also re¯ect an in vivo intermediate between
two conformations that would be interchangeable from a
Figure 5. Both human Fen1 extrahelical 3¢-¯ap pocket mutants can interact and be stimulated by PCNA, but the normal cleavage pattern cannot be restored.
(A) Fen1 wt and mutant proteins (8 mg) were incubated with PCNA (460 ng) and pull-down experiments performed as outlined in Materials and Methods.
PCNA was detected by western blot analysis. Lane1, Fen1 (LQTKFSR) and PCNA; lane 2, Fen1 (LTFR) and PCNA; lane 3, Fen1 DP (Fen1 lacking the
PCNA binding domain) and PCNA, negative control; lane 4, Fen1 wt and PCNA, positive control; lane 5, binding of PCNA to the beads, non-speci®c control;
lane 6, 46 ng PCNA. (B) Stimulation of Fen1 wt by PCNA and BSA in the presence of the single-¯ap DNA substrate was performed as outlined in Materials
and Methods. Lanes 1 and 2, oligonucleotide (nt) markers of 20 and 22 nt and 21 and 23 nt, respectively; lane 3, no enzyme control; lane 4, PCNA control;
lanes 5±9, 0, 25, 50, 100 and 250 ng PCNA tested with 1 ng Fen1 wt; lanes 10±14, 0, 25, 50, 100 and 250 ng BSA tested with 1 ng Fen1 wt, negative control;
lanes 15 and 16, oligonucleotide (nt) markers of 20 and 22 nt and 21 and 23 nt, respectively. (C) Cleavage speci®city of the two extrahelical 3¢-¯ap pocket
mutants in the presence of PCNA. Reactions were performed as outlined in Materials and Methods. Lanes 1 and 2, oligonucleotide (nt) markers of 20 and
22 nt and 21 and 23 nt, respectively; lane 3 and 11, no enzyme control; lanes 4±8, 0, 25, 50, 100 and 250 ng PCNA tested with 100 ng Fen1 (LTFR); lane
12, PCNA control; lanes 13±17, 0, 25, 50, 100 and 250 ng PNA tested with 250 ng Fen1 (LQTKFSR); lanes 9 and 10, oligonucleotide (nt) markers of 20 and
22 nt and 21 and 23 nt. Product size in nucleotides is indicated on the left of each gel. (D) Stimulation of Fen1 wt and the two extrahelical 3¢-¯ap mutants by
PCNA. The bar graph documents the maximal stimulation 6 SEM of Fen1 wt (1 ng), Fen1 (LTFR) (100 ng) and Fen1 (LQTKFSR) (250 ng) endonuclease
activity by saturating amounts of PCNA. The stimulation was calculated as the quotient between the activity in the presence and absence of PCNA.
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double-¯ap to a single-¯ap containing a +1 5¢-¯ap, pro-
vided the single 3¢-¯ap is complementary. The 3¢-terminal
nucleotide is recognized by a region or hydrophobic pocket in
the Fen1 protein (11,16) that could accommodate a mono-
nucleotide. Our results suggest that, as proposed recently for
the archaeal A.fulgidus Fen1, binding to the 3¢-¯ap anchors the
DNA in a de®ned orientation and positions the scissile
phosphate near the active site. The kink promotes con-
formational closing of the ¯exible helical clamp and thus
can facilitate the cleavage speci®city at the 5¢-¯ap to be
cleaved.
Implications of a double-¯ap structure for DNA
transactions carried out by Fen1 in vivo
A double-¯ap DNA structure ensures speci®c recognition of
an unpaired 3¢ nucleotide at a junction in DNA replication.
Due to the universal directionality of any DNA polymerase,
replication at the lagging strand is discontinuous (reviewed in
26). This occurs every 200 bases, thus resulting in more than
107 Okazaki fragment maturation events per replication of the
human genome. During their maturation, the DNA polymerase
d holoenzyme performs strand displacement synthesis and the
Okazaki fragment is processed by the concerted action of
replication protein A, PCNA, Fen1 and subsequent ligation by
DNA ligase I (27,28). `Freezing' of the double-¯ap structure
for Fen1 is likely guaranteed by the concerted action of these
proteins, but how they are positioned around PCNA is not
known. In Sulfolobus solfataricus, where PCNA is a
heterotrimer, one subunit binds Fen1, the second DNA
polymerase and the third DNA ligase (29). This suggests
that kinking the DNA at the physiological double-¯ap DNA
would guarantee concomitant binding of Fen1 endonuclease,
DNA polymerase d and DNA ligase I to precisely coordinate
DNA synthesis, ¯ap cutting and DNA ligation. A frozen
double-¯ap structure would be the optimal contribution from
the DNA side to precisely perform the many millions of
Okazaki fragment processing events.
In long patch base excision repair it has been proposed that
DNA ligase I can act as a patch size mediator (30) that can
obviously determine proper Fen1 positioning for 5¢-¯ap
cleavage in the presence of the DNA polymerase d
holoenzyme (DNA polymerase d, PCNA and replication
factor C) (31). Again, `freezing' of the double-¯ap DNA
would guarantee proper ligation, regardless of the size of the
base excision repair patch.
Uncovering how cleavage speci®city is guaranteed by
means of the extrahelical 3¢-¯ap pocket which positions the
DNA to allow precise cleavage may explain how Fen1 deals
with its paramount role in DNA replication and in preventing a
situation in the genome that leads to unwanted genetic
exchanges and eventually to a cancerous phenotype.
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